SGLT2 inhibitors: a therapy for everybody but not for anything?

Eur J Prev Cardiol. 2024 May 11;31(7):768-769. doi: 10.1093/eurjpc/zwad372.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Treatment Outcome

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Blood Glucose
  • Hypoglycemic Agents